Examkin

Question

Difficulty: MediumNeoplastic Processes

A 42-year-old female presents to the clinic after noticing a painless lump in the anterior portion of her neck while swallowing. She has no symptoms of hyperthyroidism or hypothyroidism, and she denies any history of head or neck irradiation. Physical examination reveals a firm, mobile, 2.5-cm nodule in the right lobe of the thyroid gland. No cervical lymphadenopathy is appreciated. Laboratory testing shows a serum thyroid-stimulating hormone (TSH) level of 1.8 mIU/L (normal: 0.4-4.0 mIU/L). Arrange the following clinical interventions in the most appropriate chronological order for the definitive evaluation and management of this patient's condition, assuming findings at each step strongly suggest a primary differentiated thyroid malignancy.

  1. 1Perform a dedicated thyroid ultrasound to evaluate nodule size and sonographic features.
  2. 2Perform an ultrasound-guided fine-needle aspiration biopsy of the nodule.
  3. 3Perform a total or near-total thyroidectomy.
  4. 4Administer postoperative radioactive iodine (I-131) ablation therapy.
  5. 5Initiate lifelong levothyroxine therapy for thyroid-stimulating hormone suppression.

Answer

The correct chronological sequence is: Thyroid ultrasound, followed by fine-needle aspiration, followed by total thyroidectomy, followed by radioactive iodine ablation, and finally lifelong levothyroxine suppression therapy.
The standard diagnostic and therapeutic cascade for a thyroid nodule in a euthyroid patient dictates evaluating structure before attempting tissue sampling. Therefore, an ultrasound is the first indicated step. Because the TSH is normal, a radionuclide uptake scan is bypassed. If the ultrasound reveals a solid nodule greater than 1 cm or highly suspicious features, an FNA biopsy is sequentially performed to secure a cytological diagnosis. Upon confirming malignancy, a total thyroidectomy is the definitive primary management. In the postoperative period, radioactive iodine ablation is commonly indicated to eradicate residual normal tissue or micrometastases. Finally, the patient must be maintained on lifelong levothyroxine, carefully dosed to suppress TSH and thus minimize the risk of tumor recurrence.

Step-by-Step Solution

1
Evaluate the clinical presentation and initial laboratory findings.
The patient has a 2.5-cm thyroid nodule and is euthyroid (normal TSH).
A normal or elevated TSH indicates the nodule is not autonomously hyperfunctioning (a 'cold' nodule), which carries a higher risk of malignancy and requires immediate structural evaluation rather than a radionuclide scan.
2
Order the most appropriate initial imaging modality.
A dedicated thyroid ultrasound is performed.
Ultrasound accurately sizes the nodule and checks for suspicious sonographic patterns such as microcalcifications, hypoechogenicity, or irregular margins.
3
Obtain a definitive cytological diagnosis.
An ultrasound-guided fine-needle aspiration (FNA) biopsy is conducted.
Tissue sampling is necessary to differentiate between benign and malignant etiologies to dictate the extent of surgical intervention.
4
Execute the primary therapeutic and staging procedure.
A total thyroidectomy is performed.
For a confirmed malignancy >1 cm (such as papillary or follicular carcinoma), surgical resection is the standard of care to remove the primary tumor.
5
Administer adjuvant treatment to prevent recurrence.
Radioactive iodine (I-131) ablation is administered.
I-131 specifically targets and destroys remnant normal thyroid tissue and microscopic metastatic foci, which also facilitates future surveillance using thyroglobulin levels.
6
Establish a long-term maintenance and risk-reduction regimen.
Levothyroxine therapy is initiated.
Exogenous levothyroxine prevents clinical hypothyroidism and suppresses TSH secretion from the pituitary, removing a potent growth stimulus for any residual neoplastic cells.

Key Concept

The algorithmic workup of a euthyroid patient with a thyroid nodule requires sequential progression from non-invasive imaging (ultrasound) to minimally invasive diagnosis (fine-needle aspiration), followed by definitive resection (thyroidectomy), adjuvant ablation (radioactive iodine), and long-term hormonal suppression.
Estimated Time:1m 30s
Rate this question

Topics

Neoplastic Processes

More questions from this topic